These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 28272799)

  • 1. Positron emission tomography/computed tomography after primary transoral robotic surgery for oropharyngeal squamous cell carcinoma.
    Hobelmann K; Luginbuhl A; Bar-Ad V; Keane W; Curry J; Cognetti D
    Laryngoscope; 2017 Sep; 127(9):2050-2056. PubMed ID: 28272799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional outcomes, feasibility, and safety of resection of transoral robotic surgery: single-institution series of 35 consecutive cases of transoral robotic surgery for oropharyngeal squamous cell carcinoma.
    Lörincz BB; Möckelmann N; Busch CJ; Knecht R
    Head Neck; 2015 Nov; 37(11):1618-24. PubMed ID: 24955923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation.
    Dhanireddy B; Burnett NP; Sanampudi S; Wooten CE; Slezak J; Shelton B; Shelton L; Shearer A; Arnold S; Kudrimoti M; Gal TJ
    Am J Otolaryngol; 2019; 40(5):673-677. PubMed ID: 31201038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of follow-up FDG-PET/CT in the management and prognosis of patients with HPV-positive oropharyngeal squamous cell carcinoma.
    Taghipour M; Marcus C; Califano J; Fakhry C; Subramaniam RM
    J Med Imaging Radiat Oncol; 2015 Dec; 59(6):681-6. PubMed ID: 26768092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The negative predictive value of FDG PET/CT staging in early oropharyngeal squamous cell carcinoma and implications to transoral robotic surgery patient selection.
    Tapia M; Manji J; Dhillon K; Kleid S; Flatman S; Prasad J; Cardin A; Fua T; Rischin D; Dixon B; J R Magarey M
    Oral Oncol; 2022 Dec; 135():106213. PubMed ID: 36274346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Fludeoxyglucose F 18-Labeled Positron Emission Tomography and Computed Tomography With the Detection of Oropharyngeal Cancer Recurrence.
    Sivarajah S; Isaac A; Cooper T; Zhang H; Puttagunta L; Abele J; Biron V; Harris J; Seikaly H; O' Connell DA
    JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1037-1043. PubMed ID: 30242338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Recurrent and Metastatic HPV-Positive Oropharyngeal Squamous Cell Carcinoma after Transoral Robotic Surgery.
    Sims JR; Van Abel K; Martin EJ; Lohse CM; Price DL; Olsen KD; Moore EJ
    Otolaryngol Head Neck Surg; 2017 Jul; 157(1):69-76. PubMed ID: 28374634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: comparative effectiveness study.
    Taghipour M; Mena E; Kruse MJ; Sheikhbahaei S; Subramaniam RM
    Nucl Med Commun; 2017 Mar; 38(3):250-258. PubMed ID: 28099264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption.
    Li H; Torabi SJ; Park HS; Yarbrough WG; Mehra S; Choi R; Judson BL
    Laryngoscope; 2019 Aug; 129(8):1844-1855. PubMed ID: 30575965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transoral robotic versus open surgical approaches to oropharyngeal squamous cell carcinoma by human papillomavirus status.
    Ford SE; Brandwein-Gensler M; Carroll WR; Rosenthal EL; Magnuson JS
    Otolaryngol Head Neck Surg; 2014 Oct; 151(4):606-11. PubMed ID: 25049265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
    Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E
    Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occult contralateral nodal disease in oropharyngeal squamous cell carcinoma patients undergoing primary TORS with bilateral neck dissection.
    McMullen CP; Garneau J; Weimar E; Ali S; Farinhas JM; Yu E; Som PM; Sarta C; Goldstein DP; Su S; Xu W; Smith RV; Miles B; de Almeida JR
    Oral Oncol; 2019 Jun; 93():96-100. PubMed ID: 31109703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life outcomes of transoral robotic surgery with or without adjuvant therapy for oropharyngeal cancer.
    Sethia R; Yumusakhuylu AC; Ozbay I; Diavolitsis V; Brown NV; Zhao S; Wei L; Old M; Agrawal A; Teknos TN; Ozer E
    Laryngoscope; 2018 Feb; 128(2):403-411. PubMed ID: 28771728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transoral robotic surgery alone for oropharyngeal cancer: quality-of-life outcomes.
    Choby GW; Kim J; Ling DC; Abberbock S; Mandal R; Kim S; Ferris RL; Duvvuri U
    JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):499-504. PubMed ID: 25834991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transoral robotic surgery for oropharyngeal squamous cell carcinoma in the era of human papillomavirus.
    Mahmoud O; Sung K; Civantos FJ; Thomas GR; Samuels MA
    Head Neck; 2018 Apr; 40(4):710-721. PubMed ID: 29244238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival outcomes after primary transoral robotic surgery (TORS) with concurrent neck dissection for early-stage oropharyngeal squamous cell carcinoma.
    Frederiksen JG; Channir HI; Larsen MHH; Christensen A; Friborg J; Charabi BW; Rubek N; von Buchwald C
    Acta Otolaryngol; 2021 Jul; 141(7):714-718. PubMed ID: 34191671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes following TORS for HPV-positive oropharyngeal carcinoma: PEGs, tracheostomies, and beyond.
    Van Abel KM; Quick MH; Graner DE; Lohse CM; Price DL; Price KAR; Ma DJ; Moore EJ
    Am J Otolaryngol; 2019; 40(5):729-734. PubMed ID: 31303455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transoral robotic surgery for oropharyngeal carcinoma: Surgical margins and oncologic outcomes.
    Moore EJ; Van Abel KM; Price DL; Lohse CM; Olsen KD; Jackson RS; Martin EJ
    Head Neck; 2018 Apr; 40(4):747-755. PubMed ID: 29327784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locoregional Recurrence in p16-Positive Oropharyngeal Squamous Cell Carcinoma After TORS.
    Carey RM; Brody RM; Shimunov D; Shinn JR; Mady LJ; Rajasekaran K; Cannady SB; Lin A; Lukens JN; Bauml JM; Cohen RB; Basu D; O'Malley BW; Weinstein GS; Newman JG
    Laryngoscope; 2021 Dec; 131(12):E2865-E2873. PubMed ID: 34076275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and Gastrostomy Prevalence in Patients With Oropharyngeal Cancer Treated With Transoral Robotic Surgery vs Chemoradiotherapy.
    Sharma A; Patel S; Baik FM; Mathison G; Pierce BH; Khariwala SS; Yueh B; Schwartz SM; Méndez E
    JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):691-7. PubMed ID: 27347780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.